SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to record levels, alongside bullish analyst upgrades highlighting sovereign AI and customized-software opportunities, is driving attention. Bulls are celebrating the breakout and speculating about a short squeeze, while bears argue the valuation is stretched and warn of a pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry and expected index-fund buying, alongside optimism about a planned NIH cancer-vaccine initiative and the companys personalized cancer-vaccine program, are driving attention. Traders debate whether the surge reflects durable pipeline prospects or temporary index flows and momentum, with skeptics pointing to the companys losses and valuation.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

SpaceXs agreement to acquire Grain Managements 800 MHz spectrum portfolio has raised fears that it could intensify competition for AST SpaceMobile, contributing to a sharp, high-volume selloff. Traders are divided: some view the deal as a threat, while others argue ASTSs carrier-partner model and access to operators spectrum could become more valuable as SpaceX competes with those carriers.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

A sharp advance and breakout attempt near the 52-week high has fueled bullish talk of a gamma ramp and potential short squeeze, with traders pointing to call-option activity and warrants. Others caution that no confirmed news catalyst is evident and question whether the rally will hold, citing possible dilution and recurring hype around Ryan Cohen or Roaring Kitty.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile shares are under pressure after SpaceX agreed to acquire Grain Managements 800 MHz spectrum licenses, raising concerns that Starlink Mobile could eventually compete with established U.S. wireless carriers. Traders are split on whether the selloff overstates a distant threat given the infrastructure and capacity hurdles, with some viewing the drop as a buying opportunity and others warning of future disruption.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics announced MSToronto 2026 data presentationsparticularly late-breaking initial azer-cel findings in progressive MS, alongside BRIUMVI trial updatesare driving attention. Traders see the late-breaking slot as encouraging but not proof of efficacy, while also looking ahead to Sub-Q trial results and speculating about a potential buyout.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A sharp rebound through repeatedly cited resistance has fueled breakout and short-covering talk, alongside speculation that U.S. regulators may temporarily allow sales of certain peptidesa potential growth opportunity for Hims. Bulls see further momentum, while skeptics warn the move could fade like prior rallies; no peptide approval is confirmed.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is drawing attention around the Sanofi Phase 3 COVID-flu combination trial, whose EU authorization and potential milestone payment have bolstered interest in the partnership and Matrix-M platform. Traders also debate whether a Russian suspected-plague scare and broader vaccine-sector momentum amplified the rally, while many frame the move as a possible short squeeze and caution that the outbreak link is unverified.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflakes stronger-than-expected quarterly results and raised outlook, attributed in part to accelerating AI-related demand and platform consumption, have driven a sharp rally. Traders are divided between seeing a durable AI growth reacceleration and warning that the valuation is stretched and the post-earnings surge may invite profit-taking.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts launch of its Microsoft-Decision-1 model is drawing attention as traders connect the new AI product to the stocks rise. The community is split between optimism about Microsofts AI and cloud momentum and skepticism that the rally is justified amid valuation and AI-spending concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?

Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders? Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 29, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH

ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTHPR NewswireNEW YORK, Sept. 28, 2026 NEW YORK, Sept. 28, 2026 /PRNewswire/ --Class Action Attorney Juan Monteverde...

Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?

Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders? Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 11, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lantheus Holdings, Inc. (NASDAQ: LNTH) to Curium US Holdings LLC for $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments...

Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?

Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 7, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading

Equity

Decisions are due by August 23 at the latest on therapies ranging from an mRNA flu vaccine to a gene therapy for a rare metabolic disorder, putting biotech investors on high alert. 


$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lantheus Holdings, Inc. (NASDAQ: LNTH) PR Newswire NEW YORK, Aug. 3, 2026 NEW YORK, Aug. 3, 2026 /PRNewswire...

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 3, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Lantheus Holdings, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire MILWAUKEE, Aug. 3, 2026 MILWAUKEE, Aug...

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Lantheus Holdings Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$LNTH 
 
Lantheus filed supplemental proxy disclosures ahead of the Oct 14 shareholder vote on the Curium buyout, and the numbers inside Morgan Stanley's fairness opinion are worth a look. 
 
Terms: 102.50 in cash per share, plus a contingent value right worth up to 12.00 more across eight sales milestones. 
 
Morgan Stanley's DCF put standalone value at 88.10 to 118.60 per share. Its public-company comps analysis came in lower: 63.85 to 84.20. 
 
So the 102.50 deal price sits mid-range of the DCF but above the entire comps range. The Street's own targets (98 to 129, twelve analysts) put the bid in the lower half of their band. 
 
One structural note: the merger needs a majority of all outstanding shares, and abstentions count as no votes. Watching the vote count, not just the price.

Krypton Research

$LNTH another approval. Scam ass management gave this CO away for free. And golden parachute.

Happ-E

$LNTH / Curium have to file HSR by today. 
 
Not a clearance deadline. A filing deadline — written into the merger agreement so one side can't stall the clock by sitting on the paperwork. 
 
Boring covenant. It's also why deals with motivated buyers close faster than deals without.

Mergerbrief.com

$LNTH Ain't gonna matter but voted full Against this scammy golden parachute crew. Y'all can foogoff.

Feed

News

Sentiment

Earnings

Fundamentals

Info

LNTH Lantheus Holdings Inc

Fundamentals

Latest LNTH News